The so-called dry skin of the diabetic patient;La peau dite sèche du patient diabétique

Revue Medicale de Liege

Volumn 60, Issue 5-6, 2005, Pages 560-563

  Uhoda, E ^a   Debatisse, B ^a   Paquet, P ^a   Pierard Franchimont C ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Diabetes mellitus; Season; Stratum corneum; Trophic alteration; Xerosis

Indexed keywords

EMOLLIENT AGENT; HUMECTANT;

AGING; ATOPIC DERMATITIS; DESQUAMATION; DIABETES MELLITUS; DRY SKIN; ENDOCRINE DISEASE; HUMAN; METABOLIC DISORDER; POSTMENOPAUSE; REVIEW; SEASONAL VARIATION; STRATUM CORNEUM;

CLIMATE; DIABETES COMPLICATIONS; HUMANS; ICHTHYOSIS; RISK FACTORS; SEASONS;

EID: 21744432011     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Tsuruta D, Green K, Gessios S, et al.- The barrier function of skin: how to keep a tight lid on water loss. Trends Cell Biol, 2002, 12, 355-357.
2. Harding CR.- The stratum corneum: Structure and function in health and disease. Dermatol Ther, 2004, 17, 6-15.
3. Paquet F, Piérard-Franchimont C, Fumal I, et al.- Sensitive skin at menopause; dew point and electrometric properties of the stratum corneum. Maturitas, 1998, 28, 221-227.
4. Piérard-Franchimont C, Piérard GE.- Beyond a glimpse at seasonal dry skin. A review. Exog Dermatol, 2002, 1, 3-6.
5. Piérard GE.- What do you mean by dry skin? Dermatologica, 1989, 179, 1-2.
6. Piérard-Franchimont C, Piérard GE.- Entre factice et factuel, de la peau sèche à la peau rêche. Rev Med Liège, 2000, 55, 945-949.
7. Piérard GE, Goffin V, Hermanns-Lê T, Piérard- Franchimont C.- Corneocyte desquamation. Int J Mol Med, 2000, 6, 217-221.
8. Man MQ, Elias PM, Feigold KR.- Fatty acids are required for epidermal permeability barrier function. J Clin Invest, 1993, 92, 791-798.
9. Lucker GPH, Heremans AMC, Boegheim PJ, et al.-Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br J Dermatol, 1997, 136, 71-75.
10. Uhoda E, Petit L, Piérard-Franchimont C, Piérard GE.-Ultraviolet light-enhanced visualization of cutaneous signs of carotene and vitamin A dietary deficiency. Acta Clin Belg, 2004, 59, 97-101.
11. Gloor M.- How do dermatological vehicles influence the horny layer? Skin Pharmacol Physiol, 2004, 7, 267-273.
12. Rawlings AV.- Trends in stratum corneum research and the management of dry skin conditions. Int J Cosmet Sci, 2003, 25, 63-95.
13. Rawlings AV, Canestrari DA, Dobkowski B.- Moisturizer technology versus clinical performance. Dermatol Ther, 2004, 17, 49-56.
14. Piérard GE, Nikkels-Tassoudji N, Arrese JE, et al.-Dermo-epidermal stimulation elicited by a β-lipohydroxyacid: a comparison with salicylic acid and all-trans-retinoic acid. Dermatology, 1997, 194, 398-401.
15. Piérard-Franchimont C, Goffin V, Piérard GE.- Modulation of human stratum corneum properties by salicylic acid and all-trans-retinoic acid. Skin Pharmacol Appl Skin Physiol, 1998, 11, 266-272.
16. Uhoda E, Piérard-Franchimont C, Petit L, Piérard GE.-Hydroxyacids. In : Cosmeceuticals. Drugs vs Cosmetics. 2ème edition. Ed. P. Elsner, H. Maibach. Publ. Marcel Dekker, New York, 2005, pp 207-218.
17. Loden M.- Biophysical methods of providing objective documentation of the effects of moisturizing creams. Skin Res Technol, 1995, 1, 101-108.
18. Fischer TW, Wigger-Alberti W, Elsner P.- Assessment of «dry skin»: current bioengineering methods and test designs. Skin Pharmacol Appl Skin Physiol, 2001, 14, 183-195.
19. Serup J, Winther A, Blichmann C.- A simple method for the study of scale pattern and effects of a moisturizer-qualitative and quantitative evaluation by D-Squame® tape compared with parameters of epidermal hydration. Clin Exp Dermatol, 1989, 14, 277-282.
20. Berardesca E.- EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res Technol, 1996, 3, 126-132.
21. Uhoda E, Paye M, Piérard GE.- Comparative clinical and electrometric assessments of the impact of surfactants on forearm skin. Exog Dermatol, 2003, 2, 64-69.
22. Piérard-Franchimont C, Letawe C, Goffin V, Piérard GE.- Skin water-holding capacity and transdermal estrogen therapy for menopause: A pilot study. Maturitas, 1995, 22, 151-154.
23. Goffin V, Piérard-Franchimont C, Piérard GE.- Passive sustainable hydration of the stratum corneum following surfactant challenge. Clin Exp Dermatol, 1999, 24, 308-311.
24. Van Cromphaut I, Fumal I, Jacquemin D, et al.- Electrometric evaluation using the passive sustainable hydration test. J Environ Med, 1999, 1, 47-50.
25. Piérard GE.- EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: Evaluation by stratum corneum strippings. Skin Res Technol, 1996, 2, 3-11.
26. Piérard-Franchimont C, Henry F Piérard GE.- The SACD method and the SLRS squamometry tests revisited. Int J Cosmet Sci, 2000, 22, 437-446.
27. Piérard-Franchimont C, Petit L, Piérard GE.- Skin surface patterns of xerotic legs: the flexural and accretive types. Int J Cosmet Sci, 2001, 23, 121-126.
28. Flagothier C, Quatresooz P, Bourguignon R, Piérard-Franchimont C, Piérard GE.- Stigmates cutanés du diabète. Rev Med Liège, 2005, 60, 553-559.
29. Rurangirwa A, Piérard-Franchimont C, Piérard GE.-Growth of Candida albicans on the stratum corneum of diabetic and non-diabetic patients. Mycoses, 1990, 33, 253-255.
30. Piérard-Franchimont C, Goffin V, Piérard GE.- Comparative stratum corneum tolerance to antiseptic cleansing products. J Dermatol Treat, 1999, 10, 195-198.
31. Pham HT, Exelbert L, Segal-Owens AC, et al.- A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ost Wound Manag, 2002, 48, 30-36.
32. Uhoda E, Piérard-Franchimont C, Debatisse B, et al.-Repair kinetics of stratum corneum under repeated insults. Exog Dermatol, 2004, 3, 7-11.
33. Wolk M, Danon D.- Promotion of wound healing by yeast glucan evaluated on single animals. Med Biol, 1985, 63, 73-80.
34. Babineau TJ, Hackford A, Kenler A, et al.- A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg, 1994, 129, 1204-1210.
35. Zulu F, Suter F, Biltz H, et al.- Improving skin function with CM-glucan, a biological response modifier from yeast. Int J Cosmet Sci, 1998, 20, 779-786.
36. Bierhaus A, Hofmann MA, Ziegler R, et al.- AGEs and their interaction with AGE-receptors in vascular diseasse and diabetes mellitus. I- The AGE concept. Cardiovas Res, 1998, 37, 586-600.
37. Hipkiss AR, Brownson CA.- Possible new role for the anti-ageing peptide carnosine. Cell Mol Life Sci, 2000, 57, 747-753.
38. Serhan CN, Haeggstrom JZ, Leslie CC.- Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J, 1996, 10, 1147-1158.